shutterstock_1170053383casimiro-pt

Casimiro PT / Shutterstock.com

30 November 2020EuropeRory O'Neill

MSF urges EU to rid market of ‘avoidable suffering’ from SPCs

Médecins Sans Frontières (MSF) has warned that the European Commission’s commitment to the supplementary protection certificate (SPC) system risks undermining its promise to improve drug accessibility.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

WATCH: John Ward, trademarks VP and associate GC of Moderna, at INTA

5 May 2026 John Ward, vice president and associate general counsel of trademarks at Moderna, chats with Tom Phillips at INTA 2026.

Report: 85% of in-house counsel want IP service providers to embrace AI

30 April 2026 Data from Questel indicates a radical restructuring of IP professionals’ duties, as adoption and demand rates continue to rise.

Moderna loses key mRNA patent in European vaccine fight

30 April 2026 The company’s rivals convinced an EPO appeals board to revoke a patent that had been used in litigation against them over Comirnaty.

More features

US judge allows rare patent defence in ‘world’s smallest heart pump’ suit

WATCH: John Ward, trademarks VP and associate GC of Moderna, at INTA

WATCH: Interview with Ben Doranz, president and CEO, Integral Molecular

Brussels under scrutiny for IP policy as US flags risks to innovation

Squire Patton Boggs promotes partner to head Europe IP&T practice

From the courtroom: Hikma v Amarin SCOTUS oral arguments

Report: 85% of in-house counsel want IP service providers to embrace AI

Moderna loses key mRNA patent in European vaccine fight